Global Community

Esperion’s cholesterol drugs face a squeeze as drug-price scrutiny rises and rivals bring newer treatments that could pull patients away. At the same time, patent protection, international expansion, and a broader pipeline could help it keep growing—if it can navigate tougher rules and mounting competition.Read more

Glaukos faces a tough squeeze as insurers pay less for eye procedures while bigger rivals crowd into its core glaucoma treatments, which could make it harder to keep prices and win cases. The upside case hinges on whether new launches and wider coverage keep doctors adopting its next wave of therapies fast enough to offset those pressures.Read more

Kokusai Electric sits in the middle of booming chipmaking investment, but rising trade barriers and a global push to build chips at home could shut it out of key customers and partnerships. Add tougher environmental rules, higher costs, and reliance on a handful of big buyers, and the path to steady growth may be less smooth than it looks.Read more

Columbus McKinnon looks set to get a bigger boost than many expect from its Kito Crosby tie-up, as cross-selling and a strong order pipeline could lift growth faster if execution stays on track. The catch is that trade tensions, uneven project timing, and the hard work of integrating a highly leveraged deal could quickly turn those gains into choppy results.Read more

United Parks & Resorts may face a slow squeeze as fewer families, more extreme weather, and more time spent on at-home entertainment make it harder to keep people coming through the gates. At the same time, stronger bookings, popular seasonal events, and efforts to boost spending through its app and partnerships could still keep results healthier than skeptics expect.Read more

DoubleUGames leans heavily on social casino games, and shifting player habits could make it harder to keep growing and protect profits over time. A bigger push into selling directly to players and rapidly launching many new titles may help in the short run, but it also brings new rule-change and saturation risks worth understanding.Read more

SBM Offshore wins work from big offshore oil projects, but that focus also leaves it exposed if major customers slow spending or the world moves faster toward cleaner energy. See why tougher projects, rising competition, and slow progress in newer businesses could make future results less steady than they look today.Read more

A small medical tech company is pushing a portable MRI system into hospitals, offices, and even more distributed care, betting that aging populations and telemedicine make brain imaging easier to bring to the patient. The upside hinges on faster-than-expected adoption and a growing software ecosystem, but heavy losses, tough competition, and tricky global rollouts could derail the path to a self-sustaining business.Read more

Marui Group is betting that tighter links between its stores and its card business can keep customers spending more over time, helped by new premium card options and smarter use of store space. The upside looks real, but higher costs and slow growth in new card sign-ups could make it harder to turn that strategy into stronger profits.Read more